IRVINE, Calif., April 24, 2023 (GLOBE NEWSWIRE) — Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced the appointment of Jeff Farrow as Chief Financial Officer and Chief…Read More
Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer
